-
Mashup Score: 0Amyloidosis and Heart Transplantation in a New Era - 5 hour(s) ago
Background The prognosis in patients with advanced cardiac amyloidosis (CA) remains poor. Objectives We sought to describe survival post heart transplantation (HT) in amyloid compared with non-amy…
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
Myeloma Paper of the Day, January 12th, suggested by Robert Orlowski / cancer, Mayo Clinic, MD Anderson Cancer Center, Melissa A. Lyle, Myeloma Paper of the
Source: oncodaily.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 34Transplant Cardiologist - 1 year(s) ago
Heal the sick, advance the science, share the knowledge. The Department of Transplant at Mayo Clinic in Florida seeks a highly qualified transplant cardiologist to join our expanding practice in a multidisciplinary program incorporating advanced heart failure, mechanical circulatory support and heart transplantation. With over 70 heart transplants for 2023, we are a top 10 program nationally with one of the best pre- and post- transplant outcomes based on SRTR reports. We are frontline nationally for innovation and hoping to grow further. The Transplant Programs across the three Mayo Clinic sites in Florida, Arizona and Minnesota are known for their leadership in cutting edge transplant research, multidisciplinary team approach to patient care, post-graduate education, innovative approaches to patient care, and collaboration. Candidates must be board-certified/board-eligible for Advanced Heart Failure and Transplant Cardiology and have an interest in clinical service, research a…
Categories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10
Author links open overlay panel Lauren K. Truby MD, MS a, Prateeti Khazanie MD, MPH b, Maryjane Farr MD, MSc a The United Network for Organ Sharing and the Organ Procurement Transplantation Network (UNOS/OPTN) implemented a change to the heart allocation system in October 2018: the first change in 12 years. This effort was triggered by multiple issues, including increases in the number of candidates dying on the waitlist despite high-priority status and high numbers of patients with durable left ventricula
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 7Hereditary transthyretin amyloidosis presenting with spontaneous periorbital purpura: a case report - 2 year(s) ago
AbstractBackground. Amyloidosis is a systemic disorder of abnormal protein folding and deposition resulting in a range of symptoms including neuropathy, heart f
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 7Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis - PubMed - 3 year(s) ago
The recent approval of three drugs for the treatment of amyloid transthyretin (ATTR) amyloidosis, both hereditary and wild-type, has opened a new era in the care of these diseases. ATTR amyloidosis is embedded in its pathophysiology, and the drugs target critical steps of the amyloid cascade. In add …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2‘It’s almost like a love letter’: ICU doctor paints for his colleagues treating COVID patients - 3 year(s) ago
Chicago ICU doctor paints for his colleagues treating COVID patients. “It’s almost like a love letter.”
Source: chicagotribune.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4
Original Article from The New England Journal of Medicine — CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet
Excited to share @MayoClinic experience with #amyloid and🫀transplant 📌 Post tx survival #amyloid = non-amyloid pts 📌 ⬇️ wait times for #amyloid after allocation change 📌 ⬇️ multi- organ tx with TTR targeted therapies @MayoAmyloid https://t.co/QBdbtUnHyh